期刊文献+

乳腺导管原位癌伴微浸润发生腋窝淋巴结转移的相关因素分析 被引量:3

Risk factor analysis of axillary lymph node metastasis in patients with breast ductal carcinoma in situ with microinvasion
原文传递
导出
摘要 目的探讨乳腺导管原位癌伴微浸润(breast ductal carcinoma in situ withmicroinvasion,DCIS-Mi)患者发生腋窝淋巴结转移的危险因素。方法应用回顾性调查方法收集2000年1月至2008年10月可手术乳腺DCIS-Mi病例共174例,分析有无腋窝淋巴结转移患者的不同分子病理特征,并通过χ2检验、Spearman检验以及Logistic回归分析筛选腋窝淋巴结转移的危险因素。结果 174例DCIS-Mi患者中,有腋窝淋巴结转移者9例(5.17%)。DCIS-Mi病灶中,DCIS级别与腋窝淋巴结转移呈正相关(r=0.262,P=0.000),激素受体状态与腋窝淋巴结转移呈负相关(r=-0.192,P=0.011)。经Logistic回归分析各因素相互调整后,DCIS高级别(OR=37.191,P=0.005)和肿瘤直径≥4.0cm(OR=29.634,P=0.023)是DCIS-Mi病灶发生转移的高危因素。结论在DCIS-Mi患者中,DCIS级别高和肿瘤直径≥4.0cm者容易发生腋窝淋巴结转移,对此类患者进行个体化治疗是必要的。 Objective To study the risk factors of axillary lymph node metastasis in patients with breast ductal carcinoma in situ with microinvasion (DCIS-Mi). Methods Totally 174 cases of DCIS-Mi from January 2000 to December 2008 were involved for retrospective survey. The molecular pathologic features were compared between the patients with axillary lymph node metastasis and the patients without. The risk factors of axillary lymph node metastasis were screened out by Chi-square test, Spearman test and Logistic regression analysis. Results In 174 eases of DCIS-Mi, 9 (5. 17% ) cases were observed with axillary lymph node metastasis. The tumor grade of DCIS was found to be positively correlated with the risk of axillary lymph node metastasis ( r = 0. 262, P = 0. 000). Patients with hormone receptor positive had decreased risk of axillary lymph node metastasis ( r = -0. 192, P = 0. 011 ). After adjusted by various factors in Logistic regression analysis, high grade and tumor diameter ≥ 4. 0 cm were the high risk factors of axillary lymph node metastasis in DCIS-Mi ( OR -- 37. 191, P = 0. 005 ; OR = 29. 634, P = 0. 023, respectively). Conclusion In DCIS-Mi, high tumor grade and tumor diameter ≥ 4.0 cm were the risk factors of axillary lymph node metastasis. It is necessary to give the individualized treatment for these patients.
出处 《中华乳腺病杂志(电子版)》 CAS 2012年第5期25-28,共4页 Chinese Journal of Breast Disease(Electronic Edition)
基金 国家自然科学基金资助项目(31060161)
关键词 导管原位癌 微浸润 腋窝淋巴结转移 ductal carcinoma in situ microinvasion axillary lymph node metastasis
  • 相关文献

参考文献13

二级参考文献75

  • 1郑雅娟,邓甬川.乳腺癌预后的分子标志物研究进展[J].国外医学(肿瘤学分册),2005,32(4):286-288. 被引量:8
  • 2杜鹏,翟振武,陈卫.中国人口老龄化百年发展趋势[J].人口研究,2005,29(6):90-93. 被引量:290
  • 3王跃华,赵铁,周娜.雌激素受体、孕激素受体、p53基因和C-erbB-2在乳腺癌组织中的表达及意义[J].中国临床保健杂志,2006,9(4):360-361. 被引量:13
  • 4张琼,朱玉兆.c-erbB-2、p53、PCNA、ER、PR及TopoⅡ在乳腺癌的表达及其临床意义[J].蚌埠医学院学报,2006,31(5):447-450. 被引量:5
  • 5<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 6Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 2007,25 ( 33 ) : 5287-5312.
  • 7Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol,2007,25( 1 ) :118-145.
  • 8Hanna WM, Kwok K. Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm. Mod Pathol,2006,19(4) :481-487.
  • 9Gong Y, Sweet W, Duh YJ, et al. Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. Am J Clin Pathol,2009,131 (4) :490-497.
  • 10Dietel M, Ellis IO, Hofler H, et al. Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Arch ,2007,451 ( 1 ) : 19-25.

共引文献293

同被引文献16

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部